Faculty

Institution

Unit

Venue

Michael Wotman

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Department Of Head And Neck Surgery, Section Of Speech Pathology And Audiology

Department Of Thoracic-Head And Neck Med Onc

The University of Texas MD Anderson Cancer Center

NoneMichael Wotman is currently serving as a Head And Neck Surgery faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Wotman

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 49: The Per3-Rorb Axis Defines a Tumor-Suppressive Circadian State Associated With Improved Survival in Head and Neck Squamous Cell Carcinoma.. Cancer Research (2026)

oncologyoncogenesabstract 49cancer growthcell biologyper3-rorb axistumor-suppressive circadian stateradiation oncologytumor biologycancer cellscancer researchcancer biologytumor suppressorsneck oncology

Abstract Lb-C008: Replication Stress Coupled to Cgas–Sting Activation Defines an Innate Immune–Inflamed Transcriptional State in Head and Neck Squamous Cell Carcinoma That is Enriched for Hpv-Positive Disease. Cancer Immunology Research (2026)

immune responsesimmunologyreplication stresscell biologyinnate immune systemmedical virologytranscriptional statecancer cellshpv-positive diseasecancer-associated viruspathogenesisviral oncology

Development of Glioblastoma Multiforme in Patients With Human Papillomavirus‐Positive Oropharyngeal Squamous Cell Carcinoma: A Case Series. Cancer Reports (2026)

oncologyoral canceroral pathologymalignant diseasecase seriespathologybrain tumor researchneuro-oncologyradiation oncologyglioblastoma multiformegliomascancer-associated virusneck oncology

Comparing Recist, Choi, Modified Choi (Mchoi) and Viable Tumor Volume (Vtv) in Predicting Clinical Benefit of Vascular Endothelial Growth Factor Receptor Inhibitors (Vegfri) in Patients (Pts) With Recurrent/Metastatic (R/M) Adenoid Cystic Carcinoma (Acc).. Journal of Clinical Oncology (2025)

oncologymetastasisradiation oncologycancer treatmentmolecular cancer

Development and Validation of an Assay to Quantify Plasma Circulating Tumor Human Papillomavirus Dna for 13 High-Risk Types That Cause 98% of Hpv-Positive Cancers. Head and Neck Pathology (2025)

oncologyviral diagnosticsmolecular diagnosticsviral oncologycause 98high-risk typesdiagnostic virologypathologymedical virologyhpv-positive cancersvirologycancer detectioncancer-associated viruscancer researchinfectious diseases

Figure S3 From Time Dependency for Human Papillomavirus Circulating Tumor Dna Detection After Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer. (2025)

oncologyprognostic biomarkersmolecular diagnosticslocalized anal cancertime dependencypathologybiomarkersradiation oncologycancer cellsmolecular pathologycancer detectioncancer researchradiologycancer imagingfigure s3

Incidence and Outcomes of Radiation-Associated Second Primary Malignancies in Hpv-Positive Oropharyngeal Cancer: Long-Term Follow-Up of the Quarterback De-Escalation Trials. Oral Oncology (2025)

oncologyhpv-positive oropharyngeal canceroral pathologycancer carepathologyradiation oncologyoral cancercancer researchquarterback de-escalation trialslong-term follow-upneck oncology

Misclassification of P16-Positive, Hpv-Negative Patients Biases De-Escalation Trials. The Lancet Oncology (2025)

epidemiologymedicinecancer caremedical virologyclinical epidemiologyhpv-negative patientscancer-associated virusclinical trials

Trastuzumab Deruxtecan in Her2-Low or Her2-Mutant Recurrent/Metastatic Secretory Gland Cancers of the Head and Neck: A Case Series. Journal of the National Comprehensive Cancer Network (2025)

oncologytrastuzumab deruxtecanmetastasisoral pathologymalignant diseasepathologysurgical pathologydermatologycase seriescancer researchneck oncology

Association of Human Papillomavirus Genotype and Phylogenic Clade With Oropharyngeal Cancer Outcomes. The Oncologist (2024)

Michael T WotmanTara Ivic-PavlicicWilliam H WestraBrandon GoldMegan D’AndreaEric M GendenKrzysztof MisiukiewiczScott A RoofEmanuela TaioliMarshall Posner

oncologyphylogenic cladehuman papillomavirus genotypegeneticsoropharyngeal cancer outcomes

1
2
3
4
5
10 / page

Michael Wotman

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Department Of Head And Neck Surgery, Section Of Speech Pathology And Audiology

Department Of Thoracic-Head And Neck Med Onc

The University of Texas MD Anderson Cancer Center

NoneMichael Wotman is currently serving as a Head And Neck Surgery faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Wotman

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 49: The Per3-Rorb Axis Defines a Tumor-Suppressive Circadian State Associated With Improved Survival in Head and Neck Squamous Cell Carcinoma.. Cancer Research (2026)

immune responsesimmunologyreplication stresscell biologyinnate immune systemmedical virologytranscriptional statecancer cellshpv-positive diseasecancer-associated viruspathogenesisviral oncology

Development of Glioblastoma Multiforme in Patients With Human Papillomavirus‐Positive Oropharyngeal Squamous Cell Carcinoma: A Case Series. Cancer Reports (2026)

oncologyoral canceroral pathologymalignant diseasecase seriespathologybrain tumor researchneuro-oncologyradiation oncologyglioblastoma multiformegliomascancer-associated virusneck oncology

oncologymetastasisradiation oncologycancer treatmentmolecular cancer

Development and Validation of an Assay to Quantify Plasma Circulating Tumor Human Papillomavirus Dna for 13 High-Risk Types That Cause 98% of Hpv-Positive Cancers. Head and Neck Pathology (2025)

Figure S3 From Time Dependency for Human Papillomavirus Circulating Tumor Dna Detection After Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer. (2025)

Incidence and Outcomes of Radiation-Associated Second Primary Malignancies in Hpv-Positive Oropharyngeal Cancer: Long-Term Follow-Up of the Quarterback De-Escalation Trials. Oral Oncology (2025)

oncologyhpv-positive oropharyngeal canceroral pathologycancer carepathologyradiation oncologyoral cancercancer researchquarterback de-escalation trialslong-term follow-upneck oncology

Misclassification of P16-Positive, Hpv-Negative Patients Biases De-Escalation Trials. The Lancet Oncology (2025)

epidemiologymedicinecancer caremedical virologyclinical epidemiologyhpv-negative patientscancer-associated virusclinical trials

Trastuzumab Deruxtecan in Her2-Low or Her2-Mutant Recurrent/Metastatic Secretory Gland Cancers of the Head and Neck: A Case Series. Journal of the National Comprehensive Cancer Network (2025)

oncologytrastuzumab deruxtecanmetastasisoral pathologymalignant diseasepathologysurgical pathologydermatologycase seriescancer researchneck oncology

Association of Human Papillomavirus Genotype and Phylogenic Clade With Oropharyngeal Cancer Outcomes. The Oncologist (2024)

Michael T WotmanTara Ivic-PavlicicWilliam H WestraBrandon GoldMegan D’AndreaEric M GendenKrzysztof MisiukiewiczScott A RoofEmanuela TaioliMarshall Posner

oncologyphylogenic cladehuman papillomavirus genotypegeneticsoropharyngeal cancer outcomes

1
2
3
4
5
10 / page